Researchers developed a novel recombinant vaccine called NIPRAB that shows robust immunization against Nipah virus in animal models and may be effective against other viruses in the same family.

New research lays foundation for upcoming clinical trial for patients with epidermolysis bullosa

To unravel programmed cell death pathways, investigators examine a molecule deemed unimportant, and find new function.

Jefferson researchers discover potential therapy for major disease symptom

A diagnostic test based on cytokine profile could help distinguish between infection and other diseases.

The discovery could influence oncologists’ treatment recommendations.